$SUPN Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in SUPERNUS PHARMACEUTICALS, INC..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of all insider trading transactions in SUPERNUS PHARMACEUTICALS, INC.. Get notifications about new insider transactions in SUPERNUS PHARMACEUTICALS, INC. for free.

Page:   1 2 3 4 4 next >

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Apr 14 2021SUPNSUPERNUS PHARMACEU ...Martin Tami TillotsonSr. V.P., Regulator ...Option ExerciseM12.983,12540,5636,250
Apr 14 2021SUPNSUPERNUS PHARMACEU ...Martin Tami TillotsonSr. V.P., Regulator ...Option ExerciseM12.983,12540,5639,375
Apr 14 2021SUPNSUPERNUS PHARMACEU ...Martin Tami TillotsonSr. V.P., Regulator ...SellS31.983,12599,93886,32689.5 K to 86.3 K (-3.49 %)
Apr 14 2021SUPNSUPERNUS PHARMACEU ...Martin Tami TillotsonSr. V.P., Regulator ...BuyM12.983,12540,56389,45186.3 K to 89.5 K (+3.62 %)
Apr 14 2021SUPNSUPERNUS PHARMACEU ...Martin Tami TillotsonSr. V.P., Regulator ...SellS29.983,12593,70286,32689.5 K to 86.3 K (-3.49 %)
Apr 14 2021SUPNSUPERNUS PHARMACEU ...Martin Tami TillotsonSr. V.P., Regulator ...BuyM12.983,12540,56389,45186.3 K to 89.5 K (+3.62 %)
Mar 30 2021SUPNSUPERNUS PHARMACEU ...Khattar Jack A.President, CEOSellJ0.0010,00001,058,4501.1 M to 1.1 M (-0.94 %)
Mar 30 2021SUPNSUPERNUS PHARMACEU ...Khattar Jack A.President, CEOBuyJ0.0010,0000516,466506.5 K to 516.5 K (+1.97 %)
Feb 23 2021SUPNSUPERNUS PHARMACEU ...Kelly James PatrickExecutive Vice-Pres ...Option ExerciseA29.6115,000444,15015,000
Feb 23 2021SUPNSUPERNUS PHARMACEU ...Rubin JonathanSVP, Chief Medical ...Option ExerciseA29.6125,000740,25025,000
Feb 23 2021SUPNSUPERNUS PHARMACEU ...Martin Tami TillotsonSr. V.P., Regulator ...Option ExerciseA29.6117,000503,37017,000
Feb 23 2021SUPNSUPERNUS PHARMACEU ...Mottola FrankSVP, Quality, GMP O ...Option ExerciseA29.6117,000503,37017,000
Feb 23 2021SUPNSUPERNUS PHARMACEU ...Bhatt Padmanabh P.Sr. VP of IP, CSOOption ExerciseA29.6117,000503,37017,000
Feb 23 2021SUPNSUPERNUS PHARMACEU ...Khattar Jack A.President, CEOOption ExerciseA29.61200,0005,922,000200,000
Dec 22 2020SUPNSUPERNUS PHARMACEU ...Schwabe Stefan K.F.Executive Vice Pres ...Option ExerciseM12.9846,347601,5840
Dec 22 2020SUPNSUPERNUS PHARMACEU ...Schwabe Stefan K.F.Executive Vice Pres ...SellS22.1046,3471,024,4632,77249.1 K to 2.8 K (-94.36 %)
Dec 22 2020SUPNSUPERNUS PHARMACEU ...Schwabe Stefan K.F.Executive Vice Pres ...BuyM12.9846,347601,58449,1192.8 K to 49.1 K (+1,671.97 %)
Dec 15 2020SUPNSUPERNUS PHARMACEU ...Schwabe Stefan K.F.Executive Vice Pres ...Option ExerciseM12.983,65347,41646,347
Dec 15 2020SUPNSUPERNUS PHARMACEU ...Schwabe Stefan K.F.Executive Vice Pres ...Option ExerciseM9.1350,000456,5000
Dec 15 2020SUPNSUPERNUS PHARMACEU ...Schwabe Stefan K.F.Executive Vice Pres ...SellS22.003,65380,3692,7726.4 K to 2.8 K (-56.86 %)
Dec 15 2020SUPNSUPERNUS PHARMACEU ...Schwabe Stefan K.F.Executive Vice Pres ...SellS21.8650,0001,092,8956,42556.4 K to 6.4 K (-88.61 %)
Dec 15 2020SUPNSUPERNUS PHARMACEU ...Schwabe Stefan K.F.Executive Vice Pres ...BuyM12.983,65347,41656,42552.8 K to 56.4 K (+6.92 %)
Dec 15 2020SUPNSUPERNUS PHARMACEU ...Schwabe Stefan K.F.Executive Vice Pres ...BuyM9.1350,000456,50052,7722.8 K to 52.8 K (+1,803.75 %)
Nov 10 2020SUPNSUPERNUS PHARMACEU ...PATRICK GREGORY SSr. VP Chief Financ ...Option ExerciseM12.985,00064,90010,000
Nov 10 2020SUPNSUPERNUS PHARMACEU ...PATRICK GREGORY SSr. VP Chief Financ ...SellS25.005,000125,00044,46349.5 K to 44.5 K (-10.11 %)
Nov 10 2020SUPNSUPERNUS PHARMACEU ...PATRICK GREGORY SSr. VP Chief Financ ...BuyM12.985,00064,90049,46344.5 K to 49.5 K (+11.25 %)
Nov 06 2020SUPNSUPERNUS PHARMACEU ...PATRICK GREGORY SSr. VP, CFOOption ExerciseM12.985,00064,90015,000
Nov 06 2020SUPNSUPERNUS PHARMACEU ...PATRICK GREGORY SSr. VP, CFOSellS23.005,000115,00044,46349.5 K to 44.5 K (-10.11 %)
Nov 06 2020SUPNSUPERNUS PHARMACEU ...PATRICK GREGORY SSr. VP, CFOBuyM12.985,00064,90049,46344.5 K to 49.5 K (+11.25 %)
Oct 15 2020SUPNSUPERNUS PHARMACEU ...PATRICK GREGORY SSr. VP, CFOOption ExerciseM12.9815,000194,70020,000
Oct 15 2020SUPNSUPERNUS PHARMACEU ...PATRICK GREGORY SSr. VP, CFOSellS20.0315,000300,50744,46359.5 K to 44.5 K (-25.23 %)
Oct 15 2020SUPNSUPERNUS PHARMACEU ...PATRICK GREGORY SSr. VP, CFOBuyM12.9815,000194,70059,46344.5 K to 59.5 K (+33.74 %)
Aug 28 2020SUPNSUPERNUS PHARMACEU ...PATRICK GREGORY SSr.VP, Chief Financ ...GiftG0.001,120044,46345.6 K to 44.5 K (-2.46 %)
Aug 28 2020SUPNSUPERNUS PHARMACEU ...PATRICK GREGORY SSr.VP, Chief Financ ...GiftG0.001,000045,58346.6 K to 45.6 K (-2.15 %)
Jul 28 2020SUPNSUPERNUS PHARMACEU ...Khattar Jack A.President, CEOGrantA0.0015,6250506,466490.8 K to 506.5 K (+3.18 %)
Jul 15 2020SUPNSUPERNUS PHARMACEU ...Hudson Frederick M.DirectorOption ExerciseM2.568,75022,4000
Jul 15 2020SUPNSUPERNUS PHARMACEU ...Hudson Frederick M.DirectorSellS24.4492022,48518,04119 K to 18 K (-4.85 %)
Jul 15 2020SUPNSUPERNUS PHARMACEU ...Hudson Frederick M.DirectorBuyM2.568,75022,40018,96110.2 K to 19 K (+85.69 %)
Jul 13 2020SUPNSUPERNUS PHARMACEU ...Khattar Jack A.President, CEOGrantA0.0015,6250490,841475.2 K to 490.8 K (+3.29 %)
May 20 2020SUPNSUPERNUS PHARMACEU ...PATRICK GREGORY SSr.VP, Chief Financ ...Option ExerciseM12.9815,000194,70035,000
May 20 2020SUPNSUPERNUS PHARMACEU ...PATRICK GREGORY SSr.VP, Chief Financ ...SellS25.0315,000375,38046,05761.1 K to 46.1 K (-24.57 %)
May 20 2020SUPNSUPERNUS PHARMACEU ...PATRICK GREGORY SSr.VP, Chief Financ ...BuyM12.9815,000194,70061,05746.1 K to 61.1 K (+32.57 %)
May 11 2020SUPNSUPERNUS PHARMACEU ...PATRICK GREGORY SSr VP, Chief Financ ...Option ExerciseM9.1315,000136,9500
May 11 2020SUPNSUPERNUS PHARMACEU ...PATRICK GREGORY SSr VP, Chief Financ ...SellS23.1415,000347,03446,05761.1 K to 46.1 K (-24.57 %)
May 11 2020SUPNSUPERNUS PHARMACEU ...PATRICK GREGORY SSr VP, Chief Financ ...BuyM9.1315,000136,95061,05746.1 K to 61.1 K (+32.57 %)
Mar 23 2020SUPNSUPERNUS PHARMACEU ...Khattar Jack A.President, CEOSellJ0.0013,00001,068,4501.1 M to 1.1 M (-1.20 %)
Mar 23 2020SUPNSUPERNUS PHARMACEU ...Khattar Jack A.President, CEOBuyJ0.0013,0000475,216462.2 K to 475.2 K (+2.81 %)
Feb 25 2020SUPNSUPERNUS PHARMACEU ...Mottola FrankSr VP, Quality, GMP ...Option ExerciseA23.9922,000527,78022,000
Feb 25 2020SUPNSUPERNUS PHARMACEU ...Martin Tami TillotsonSr. V.P., Regulator ...Option ExerciseA23.9922,000527,78022,000
Feb 25 2020SUPNSUPERNUS PHARMACEU ...NEWHALL CHARLES W IIIDirectorOption ExerciseA23.999,305223,2279,305
Feb 25 2020SUPNSUPERNUS PHARMACEU ...NEWHALL CHARLES W IIIDirectorGrantA23.995,211125,01297,50992.3 K to 97.5 K (+5.65 %)
Feb 25 2020SUPNSUPERNUS PHARMACEU ...Bhatt Padmanabh P.Sr. VP of IP, CSOOption ExerciseA23.9935,000839,65035,000
Feb 25 2020SUPNSUPERNUS PHARMACEU ...PATRICK GREGORY SSr.VP,Chief Financi ...Option ExerciseA23.9950,0001,199,50050,000
Feb 25 2020SUPNSUPERNUS PHARMACEU ...SIEBERT JOHN MDirectorOption ExerciseA23.999,305223,2279,305
Feb 25 2020SUPNSUPERNUS PHARMACEU ...SIEBERT JOHN MDirectorGrantA23.995,211125,01260,95355.7 K to 61 K (+9.35 %)
Dec 27 2019SUPNSUPERNUS PHARMACEU ...Khattar Jack A.President, CEOGiftG0.001,10004,0002.9 K to 4 K (+37.93 %)
Dec 27 2019SUPNSUPERNUS PHARMACEU ...Khattar Jack A.President, CEOGiftG0.001,1000461,841462.9 K to 461.8 K (-0.24 %)
Dec 27 2019SUPNSUPERNUS PHARMACEU ...Khattar Jack A.President, CEOGiftG0.001,1000462,941464 K to 462.9 K (-0.24 %)
Dec 27 2019SUPNSUPERNUS PHARMACEU ...Khattar Jack A.President, CEOGiftG0.001,1000464,041465.1 K to 464 K (-0.24 %)
Aug 27 2019SUPNSUPERNUS PHARMACEU ...Khattar Jack A.President, CEOBuyP26.397,200189,982465,141457.9 K to 465.1 K (+1.57 %)
Aug 01 2019SUPNSUPERNUS PHARMACEU ...PATRICK GREGORY SSr. VP,Chief Financ ...GiftG0.002,590045,68248.3 K to 45.7 K (-5.37 %)
Jun 24 2019SUPNSUPERNUS PHARMACEU ...SIEBERT JOHN MDirectorOption ExerciseM9.1310,00091,3000
Jun 24 2019SUPNSUPERNUS PHARMACEU ...SIEBERT JOHN MDirectorBuyM9.1310,00091,30055,74245.7 K to 55.7 K (+21.86 %)
Apr 29 2019SUPNSUPERNUS PHARMACEU ...SIEBERT JOHN MDirectorOption ExerciseM9.1310,00091,30010,000
Apr 29 2019SUPNSUPERNUS PHARMACEU ...SIEBERT JOHN MDirectorBuyM9.1310,00091,30045,74235.7 K to 45.7 K (+27.98 %)
Apr 24 2019SUPNSUPERNUS PHARMACEU ...Matushansky IgorChief Medical Offic ...Option ExerciseA14.0052,064728,89652,064
Apr 24 2019SUPNSUPERNUS PHARMACEU ...Pinschewer DavidChief Scientific Of ...Option ExerciseA14.00116,4161,629,824116,416
Apr 24 2019SUPNSUPERNUS PHARMACEU ...Lengauer ChristophDirectorOption ExerciseA14.006,92496,9366,924
Mar 20 2019SUPNSUPERNUS PHARMACEU ...Khattar Jack A.President, CEOSellJ0.004,50001,081,4501.1 M to 1.1 M (-0.41 %)
Mar 20 2019SUPNSUPERNUS PHARMACEU ...Khattar Jack A.President, CEOBuyJ0.004,5000457,565453.1 K to 457.6 K (+0.99 %)
Mar 04 2019SUPNSUPERNUS PHARMACEU ...SIEBERT JOHN MDirectorOption ExerciseM9.247,45768,9030
Mar 04 2019SUPNSUPERNUS PHARMACEU ...SIEBERT JOHN MDirectorOption ExerciseM7.908,72268,9040
Mar 04 2019SUPNSUPERNUS PHARMACEU ...SIEBERT JOHN MDirectorBuyM9.247,45768,90335,74228.3 K to 35.7 K (+26.36 %)
Mar 04 2019SUPNSUPERNUS PHARMACEU ...SIEBERT JOHN MDirectorBuyM7.908,72268,90428,28519.6 K to 28.3 K (+44.58 %)
Feb 28 2019SUPNSUPERNUS PHARMACEU ...PATRICK GREGORY SSr VP, Chief Financ ...Option ExerciseM9.1320,000182,60015,000
Feb 28 2019SUPNSUPERNUS PHARMACEU ...PATRICK GREGORY SSr VP, Chief Financ ...SellS41.5320,000830,65047,89667.9 K to 47.9 K (-29.46 %)
Feb 28 2019SUPNSUPERNUS PHARMACEU ...PATRICK GREGORY SSr VP, Chief Financ ...BuyM9.1320,000182,60067,89647.9 K to 67.9 K (+41.76 %)
Feb 26 2019SUPNSUPERNUS PHARMACEU ...Khattar Jack A.President, CEOOption ExerciseA36.75300,00011,025,000300,000
Feb 26 2019SUPNSUPERNUS PHARMACEU ...Schwabe Stefan K.F.Executive Vice Pres ...Option ExerciseA36.7540,0001,470,00040,000
Feb 26 2019SUPNSUPERNUS PHARMACEU ...Bhatt Padmanabh P.Sr. VP of IP, CSOOption ExerciseA36.7535,0001,286,25035,000
Feb 26 2019SUPNSUPERNUS PHARMACEU ...PATRICK GREGORY SSr.VP,Chief Financi ...Option ExerciseA36.7540,0001,470,00040,000
Feb 26 2019SUPNSUPERNUS PHARMACEU ...Hudson Frederick M.DirectorOption ExerciseA36.7512,427456,69212,427
Feb 26 2019SUPNSUPERNUS PHARMACEU ...GEMAYEL GEORGESDirectorOption ExerciseA36.7512,427456,69212,427
Feb 26 2019SUPNSUPERNUS PHARMACEU ...Barlow CarroleeDirectorOption ExerciseA36.7512,427456,69212,427
Feb 26 2019SUPNSUPERNUS PHARMACEU ...NEWHALL CHARLES W IIIDirectorOption ExerciseA36.7512,427456,69212,427
Feb 26 2019SUPNSUPERNUS PHARMACEU ...SIEBERT JOHN MDirectorOption ExerciseA36.7512,427456,69212,427
Jan 17 2019SUPNSUPERNUS PHARMACEU ...Khattar Jack A.President, CEOGiftG0.0040002,9002.5 K to 2.9 K (+16.00 %)
Jan 17 2019SUPNSUPERNUS PHARMACEU ...Khattar Jack A.President, CEOGiftG0.004000453,065453.5 K to 453.1 K (-0.09 %)
Jan 17 2019SUPNSUPERNUS PHARMACEU ...Khattar Jack A.President, CEOGiftG0.004000453,465453.9 K to 453.5 K (-0.09 %)
Jan 17 2019SUPNSUPERNUS PHARMACEU ...Khattar Jack A.President, CEOGiftG0.004000453,865454.3 K to 453.9 K (-0.09 %)
Jul 03 2018SUPNSUPERNUS PHARMACEU ...PATRICK GREGORY SVP, Chief Financial ...Option ExerciseM9.1315,000136,95035,000
Jul 03 2018SUPNSUPERNUS PHARMACEU ...PATRICK GREGORY SVP, Chief Financial ...Option ExerciseM9.2420,000184,8000
Jul 03 2018SUPNSUPERNUS PHARMACEU ...PATRICK GREGORY SVP, Chief Financial ...SellS56.6335,0001,981,91455,97591 K to 56 K (-38.47 %)
Jul 03 2018SUPNSUPERNUS PHARMACEU ...PATRICK GREGORY SVP, Chief Financial ...BuyM9.1315,000136,95090,97576 K to 91 K (+19.74 %)
Jul 03 2018SUPNSUPERNUS PHARMACEU ...PATRICK GREGORY SVP, Chief Financial ...BuyM9.2420,000184,80075,97556 K to 76 K (+35.73 %)
Jul 02 2018SUPNSUPERNUS PHARMACEU ...Barlow CarroleeDirectorOption ExerciseA58.1510,213593,88610,213
Jun 29 2018SUPNSUPERNUS PHARMACEU ...Bhatt Padmanabh P.Sr. VP of IP, CSOOption ExerciseM9.132952,69315,000
Jun 29 2018SUPNSUPERNUS PHARMACEU ...Bhatt Padmanabh P.Sr. VP of IP, CSOSellS59.904,393263,15304.4 K to 0 (-100.00 %)
Jun 29 2018SUPNSUPERNUS PHARMACEU ...Bhatt Padmanabh P.Sr. VP of IP, CSOSellS59.943,402203,8994,3937.8 K to 4.4 K (-43.64 %)
Jun 29 2018SUPNSUPERNUS PHARMACEU ...Bhatt Padmanabh P.Sr. VP of IP, CSOBuyM9.132952,6937,7957.5 K to 7.8 K (+3.93 %)
Jun 22 2018SUPNSUPERNUS PHARMACEU ...Bhatt Padmanabh P.Sr. VP of IP, CSOOption ExerciseM9.137,20565,78215,295
Jun 22 2018SUPNSUPERNUS PHARMACEU ...Bhatt Padmanabh P.Sr. VP of IP, CSOSellS60.007,205432,3237,50014.7 K to 7.5 K (-49.00 %)
Jun 22 2018SUPNSUPERNUS PHARMACEU ...Bhatt Padmanabh P.Sr. VP of IP, CSOBuyM9.137,20565,78214,7057.5 K to 14.7 K (+96.07 %)
Jun 19 2018SUPNSUPERNUS PHARMACEU ...Schwabe Stefan K.F.Executive VP R&D, C ...Option ExerciseM9.2440,000369,6000
Jun 19 2018SUPNSUPERNUS PHARMACEU ...Schwabe Stefan K.F.Executive VP R&D, C ...Option ExerciseM7.9020,000158,0000
Jun 19 2018SUPNSUPERNUS PHARMACEU ...Schwabe Stefan K.F.Executive VP R&D, C ...SellS54.3960,0003,263,3521,96762 K to 2 K (-96.83 %)
Jun 19 2018SUPNSUPERNUS PHARMACEU ...Schwabe Stefan K.F.Executive VP R&D, C ...BuyM9.2440,000369,60061,96722 K to 62 K (+182.09 %)
Jun 19 2018SUPNSUPERNUS PHARMACEU ...Schwabe Stefan K.F.Executive VP R&D, C ...BuyM7.9020,000158,00021,9672 K to 22 K (+1,016.78 %)
May 16 2018SUPNSUPERNUS PHARMACEU ...Bhatt Padmanabh P.Sr. VP of IP, CSOOption ExerciseM9.137,50068,47522,500
May 16 2018SUPNSUPERNUS PHARMACEU ...Bhatt Padmanabh P.Sr. VP of IP, CSOOption ExerciseM9.243683,4007,500
May 16 2018SUPNSUPERNUS PHARMACEU ...Bhatt Padmanabh P.Sr. VP of IP, CSOSellS57.937,500434,4427,50015 K to 7.5 K (-50.00 %)
May 16 2018SUPNSUPERNUS PHARMACEU ...Bhatt Padmanabh P.Sr. VP of IP, CSOBuyM9.137,50068,47515,0007.5 K to 15 K (+100.00 %)
May 16 2018SUPNSUPERNUS PHARMACEU ...Bhatt Padmanabh P.Sr. VP of IP, CSOSellS57.9336821,3177,5007.9 K to 7.5 K (-4.68 %)
May 16 2018SUPNSUPERNUS PHARMACEU ...Bhatt Padmanabh P.Sr. VP of IP, CSOBuyM9.243683,4007,8687.5 K to 7.9 K (+4.91 %)
May 14 2018SUPNSUPERNUS PHARMACEU ...Bhatt Padmanabh P.Sr. VP of IP, CSOOption ExerciseM9.2410,882100,5507,868
May 14 2018SUPNSUPERNUS PHARMACEU ...Bhatt Padmanabh P.Sr. VP of IP, CSOOption ExerciseM9.2411,250103,95018,750
May 14 2018SUPNSUPERNUS PHARMACEU ...Bhatt Padmanabh P.Sr. VP of IP, CSOOption ExerciseM7.9020,000158,0000
May 14 2018SUPNSUPERNUS PHARMACEU ...Bhatt Padmanabh P.Sr. VP of IP, CSOOption ExerciseM7.9020,000158,00020,000
May 14 2018SUPNSUPERNUS PHARMACEU ...Bhatt Padmanabh P.Sr. VP of IP, CSOSellS57.9010,882630,0687,50018.4 K to 7.5 K (-59.20 %)
May 14 2018SUPNSUPERNUS PHARMACEU ...Bhatt Padmanabh P.Sr. VP of IP, CSOBuyM9.2410,882100,55018,3827.5 K to 18.4 K (+145.09 %)
May 14 2018SUPNSUPERNUS PHARMACEU ...Bhatt Padmanabh P.Sr. VP of IP, CSOSellS55.2316,250897,5437,50023.8 K to 7.5 K (-68.42 %)
May 14 2018SUPNSUPERNUS PHARMACEU ...Bhatt Padmanabh P.Sr. VP of IP, CSOBuyM9.2411,250103,95023,75012.5 K to 23.8 K (+90.00 %)
May 14 2018SUPNSUPERNUS PHARMACEU ...Bhatt Padmanabh P.Sr. VP of IP, CSOSellS52.0320,0001,040,55812,50032.5 K to 12.5 K (-61.54 %)
May 14 2018SUPNSUPERNUS PHARMACEU ...Bhatt Padmanabh P.Sr. VP of IP, CSOBuyM7.9020,000158,00032,50012.5 K to 32.5 K (+160.00 %)
May 14 2018SUPNSUPERNUS PHARMACEU ...Bhatt Padmanabh P.Sr. VP of IP, CSOSellS49.8820,000997,54412,50032.5 K to 12.5 K (-61.54 %)
May 14 2018SUPNSUPERNUS PHARMACEU ...Bhatt Padmanabh P.Sr. VP of IP, CSOBuyM7.9020,000158,00032,50012.5 K to 32.5 K (+160.00 %)
Apr 20 2018SUPNSUPERNUS PHARMACEU ...Vaughn VictorSr. VP of Sales & M ...Option ExerciseM25.307,850198,60538,400
Apr 20 2018SUPNSUPERNUS PHARMACEU ...Vaughn VictorSr. VP of Sales & M ...Option ExerciseM25.303,75094,87546,250
Apr 20 2018SUPNSUPERNUS PHARMACEU ...Vaughn VictorSr. VP of Sales & M ...Option ExerciseM12.986,25081,12525,000
Apr 20 2018SUPNSUPERNUS PHARMACEU ...Vaughn VictorSr. VP of Sales & M ...SellS49.037,850384,8559,34417.2 K to 9.3 K (-45.66 %)
Apr 20 2018SUPNSUPERNUS PHARMACEU ...Vaughn VictorSr. VP of Sales & M ...BuyM25.307,850198,60517,1949.3 K to 17.2 K (+84.01 %)
Apr 20 2018SUPNSUPERNUS PHARMACEU ...Vaughn VictorSr. VP of Sales & M ...SellS47.0610,000470,6179,34419.3 K to 9.3 K (-51.70 %)
Apr 20 2018SUPNSUPERNUS PHARMACEU ...Vaughn VictorSr. VP of Sales & M ...BuyM25.303,75094,87519,34415.6 K to 19.3 K (+24.05 %)
Apr 20 2018SUPNSUPERNUS PHARMACEU ...Vaughn VictorSr. VP of Sales & M ...BuyM12.986,25081,12515,5949.3 K to 15.6 K (+66.89 %)
Apr 09 2018SUPNSUPERNUS PHARMACEU ...Vaughn VictorSr. VP of Sales and ...Option ExerciseM12.9818,750243,37531,250
Apr 09 2018SUPNSUPERNUS PHARMACEU ...Vaughn VictorSr. VP of Sales and ...Option ExerciseM9.1326,250239,6638,750
Apr 09 2018SUPNSUPERNUS PHARMACEU ...Vaughn VictorSr. VP of Sales and ...Option ExerciseM9.2415,000138,6000
Apr 09 2018SUPNSUPERNUS PHARMACEU ...Vaughn VictorSr. VP of Sales and ...SellS45.3318,750849,9289,34428.1 K to 9.3 K (-66.74 %)
Apr 09 2018SUPNSUPERNUS PHARMACEU ...Vaughn VictorSr. VP of Sales and ...BuyM12.9818,750243,37528,0949.3 K to 28.1 K (+200.66 %)
Apr 09 2018SUPNSUPERNUS PHARMACEU ...Vaughn VictorSr. VP of Sales and ...SellS45.3326,2501,189,8999,34435.6 K to 9.3 K (-73.75 %)
Apr 09 2018SUPNSUPERNUS PHARMACEU ...Vaughn VictorSr. VP of Sales and ...BuyM9.1326,250239,66335,5949.3 K to 35.6 K (+280.93 %)
Apr 09 2018SUPNSUPERNUS PHARMACEU ...Vaughn VictorSr. VP of Sales and ...SellS45.3315,000679,9439,34424.3 K to 9.3 K (-61.62 %)
Apr 09 2018SUPNSUPERNUS PHARMACEU ...Vaughn VictorSr. VP of Sales and ...BuyM9.2415,000138,60024,3449.3 K to 24.3 K (+160.53 %)
Apr 04 2018SUPNSUPERNUS PHARMACEU ...Khattar Jack A.President & CEOSellJ0.003,80001,085,9501.1 M to 1.1 M (-0.35 %)
Apr 04 2018SUPNSUPERNUS PHARMACEU ...Khattar Jack A.President & CEOBuyJ0.003,8000453,744449.9 K to 453.7 K (+0.84 %)
Feb 16 2018SUPNSUPERNUS PHARMACEU ...PATRICK GREGORY SVP, Chief Financial ...Option ExerciseA39.4030,0001,182,00030,000
Feb 16 2018SUPNSUPERNUS PHARMACEU ...Vaughn VictorSr. VP of SalesOption ExerciseA39.4033,0001,300,20033,000
Feb 16 2018SUPNSUPERNUS PHARMACEU ...Khattar Jack A.President, CEOOption ExerciseA39.40250,0009,850,000250,000
Feb 16 2018SUPNSUPERNUS PHARMACEU ...Schwabe Stefan K.F.Executive Vice Pres ...Option ExerciseA39.4030,0001,182,00030,000
Jan 22 2018SUPNSUPERNUS PHARMACEU ...Bhatt Padmanabh P.Sr. VP of IP, CSOOption ExerciseM7.9020,000158,00040,000

Page:   1 2 3 4 4 next >

Contact us | Follow us on Twitter